(Scottsdale, Ariz.) – Making news is The Ben & Catherine Ivy Foundation, which is garnering attention in the national arena. The Scottsdale-based private brain cancer foundation was spotlighted in a recent issue of Chronicles of Philanthropy for awarding $10-million in grants to The Translational Genomics Research Institute (TGen). Additionally, producers for Lifetime Television’s “The Balancing Act” contacted Catherine Ivy about TGen for a planned segment on rare diseases.
Just last month, The Ivy Foundation released details about the grants for two research projects under TGen’s helm. One is a five-year investigation into why approximately 2% of glioblastoma multiforme (GBM) patients lives far beyond the average survival time of 18 months. The other will lead first-in-patient clinical trial studies to test new drugs that might extend the survival of GBM patients. Catherine Ivy created the foundation following her husband’s sudden death to brain cancer in 2005. It is the largest of its kind in the U.S.
SCOTTSDALE BUSINESS + Life